US Stock MarketDetailed Quotes

VERA Vera Therapeutics

Watchlist
  • 38.690
  • -1.260-3.15%
Close Apr 25 16:00 ET
  • 38.690
  • 0.0000.00%
Post 17:11 ET
2.11BMarket Cap-17195P/E (TTM)

Vera Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
12.22%102.01M
-19.51%27.03M
-13.82%21.76M
45.91%21.97M
83.64%31.26M
164.24%90.9M
102.48%33.58M
248.10%25.24M
157.43%15.06M
260.92%17.02M
Selling and administrative expenses
8.57%23.79M
-9.59%6.24M
1.22%5.66M
16.06%5.74M
37.52%6.15M
83.84%21.91M
80.19%6.91M
51.52%5.59M
89.17%4.95M
150.67%4.47M
-General and administrative expense
8.57%23.79M
-9.59%6.24M
1.22%5.66M
16.06%5.74M
37.52%6.15M
83.84%21.91M
80.19%6.91M
51.52%5.59M
89.17%4.95M
150.67%4.47M
Research and development costs
13.38%78.23M
-22.08%20.79M
-18.09%16.1M
60.51%16.23M
100.08%25.11M
206.85%68.99M
109.17%26.68M
451.52%19.66M
212.58%10.11M
328.00%12.55M
Operating profit
-12.22%-102.01M
19.51%-27.03M
13.82%-21.76M
-45.91%-21.97M
-83.64%-31.26M
-164.24%-90.9M
-102.48%-33.58M
-248.10%-25.24M
-157.43%-15.06M
-260.92%-17.02M
Net non-operating interest income expense
453.17%4.19M
206.44%904K
189.29%1.22M
881.48%1.33M
914.13%749K
15,260.00%758K
2,207.14%295K
8,300.00%420K
6,650.00%135K
-4,700.00%-92K
Non-operating interest income
355.94%7.98M
119.24%1.96M
280.60%2.16M
751.33%2.24M
6,142.31%1.62M
11,566.67%1.75M
14,800.00%894K
11,240.00%567K
13,050.00%263K
1,200.00%26K
Non-operating interest expense
281.65%3.79M
76.29%1.06M
541.50%943K
614.06%914K
640.68%874K
4,860.00%992K
2,895.00%599K
--147K
--128K
--118K
Other net income (expense)
67.89%1.83M
-44.58%470K
201.38%437K
600.00%483K
1,471.43%440K
-39.41%1.09M
443.32%848K
139.84%145K
-97.14%69K
28K
Gain on sale of security
94.19%-47K
96.88%-2K
92.57%-15K
89.06%-28K
99.65%-1K
9.30%-809K
74.09%-64K
44.51%-202K
8.90%-256K
---287K
Other non- operating income (expenses)
-1.16%1.88M
-48.25%472K
30.26%452K
57.23%511K
40.00%441K
--1.9M
--912K
--347K
--325K
--315K
Income before tax
-7.79%-95.99M
20.91%-25.65M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
-173.11%-89.06M
-92.56%-32.44M
-224.25%-24.68M
-332.15%-14.85M
-262.43%-17.09M
Income tax
0.00%1K
0.00%1K
Net income
-7.79%-95.99M
20.91%-25.66M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
-173.10%-89.06M
-92.55%-32.44M
-224.25%-24.68M
-332.15%-14.85M
-262.43%-17.09M
Net income continuous Operations
-7.79%-95.99M
20.91%-25.66M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
-173.10%-89.06M
-92.55%-32.44M
-224.25%-24.68M
-332.15%-14.85M
-262.43%-17.09M
Minority interest income
Net income attributable to the parent company
-7.79%-95.99M
20.91%-25.66M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
-173.10%-89.06M
-92.55%-32.44M
-224.25%-24.68M
-332.15%-14.85M
-262.43%-17.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-7.79%-95.99M
20.91%-25.66M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
-173.10%-89.06M
-92.55%-32.44M
-224.25%-24.68M
-332.15%-14.85M
-262.43%-17.09M
Basic earnings per share
32.84%-2.25
51.26%-0.58
50.55%-0.45
16.36%-0.46
-12.68%-0.8
-37.86%-3.35
-50.63%-1.19
-152.78%-0.91
-66.67%-0.55
-208.45%-0.71
Diluted earnings per share
32.84%-2.25
51.26%-0.58
50.55%-0.45
16.36%-0.46
-12.68%-0.8
-37.86%-3.35
-50.63%-1.19
-152.78%-0.91
-66.67%-0.55
-208.45%-0.71
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 12.22%102.01M-19.51%27.03M-13.82%21.76M45.91%21.97M83.64%31.26M164.24%90.9M102.48%33.58M248.10%25.24M157.43%15.06M260.92%17.02M
Selling and administrative expenses 8.57%23.79M-9.59%6.24M1.22%5.66M16.06%5.74M37.52%6.15M83.84%21.91M80.19%6.91M51.52%5.59M89.17%4.95M150.67%4.47M
-General and administrative expense 8.57%23.79M-9.59%6.24M1.22%5.66M16.06%5.74M37.52%6.15M83.84%21.91M80.19%6.91M51.52%5.59M89.17%4.95M150.67%4.47M
Research and development costs 13.38%78.23M-22.08%20.79M-18.09%16.1M60.51%16.23M100.08%25.11M206.85%68.99M109.17%26.68M451.52%19.66M212.58%10.11M328.00%12.55M
Operating profit -12.22%-102.01M19.51%-27.03M13.82%-21.76M-45.91%-21.97M-83.64%-31.26M-164.24%-90.9M-102.48%-33.58M-248.10%-25.24M-157.43%-15.06M-260.92%-17.02M
Net non-operating interest income expense 453.17%4.19M206.44%904K189.29%1.22M881.48%1.33M914.13%749K15,260.00%758K2,207.14%295K8,300.00%420K6,650.00%135K-4,700.00%-92K
Non-operating interest income 355.94%7.98M119.24%1.96M280.60%2.16M751.33%2.24M6,142.31%1.62M11,566.67%1.75M14,800.00%894K11,240.00%567K13,050.00%263K1,200.00%26K
Non-operating interest expense 281.65%3.79M76.29%1.06M541.50%943K614.06%914K640.68%874K4,860.00%992K2,895.00%599K--147K--128K--118K
Other net income (expense) 67.89%1.83M-44.58%470K201.38%437K600.00%483K1,471.43%440K-39.41%1.09M443.32%848K139.84%145K-97.14%69K28K
Gain on sale of security 94.19%-47K96.88%-2K92.57%-15K89.06%-28K99.65%-1K9.30%-809K74.09%-64K44.51%-202K8.90%-256K---287K
Other non- operating income (expenses) -1.16%1.88M-48.25%472K30.26%452K57.23%511K40.00%441K--1.9M--912K--347K--325K--315K
Income before tax -7.79%-95.99M20.91%-25.65M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M-173.11%-89.06M-92.56%-32.44M-224.25%-24.68M-332.15%-14.85M-262.43%-17.09M
Income tax 0.00%1K0.00%1K
Net income -7.79%-95.99M20.91%-25.66M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M-173.10%-89.06M-92.55%-32.44M-224.25%-24.68M-332.15%-14.85M-262.43%-17.09M
Net income continuous Operations -7.79%-95.99M20.91%-25.66M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M-173.10%-89.06M-92.55%-32.44M-224.25%-24.68M-332.15%-14.85M-262.43%-17.09M
Minority interest income
Net income attributable to the parent company -7.79%-95.99M20.91%-25.66M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M-173.10%-89.06M-92.55%-32.44M-224.25%-24.68M-332.15%-14.85M-262.43%-17.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -7.79%-95.99M20.91%-25.66M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M-173.10%-89.06M-92.55%-32.44M-224.25%-24.68M-332.15%-14.85M-262.43%-17.09M
Basic earnings per share 32.84%-2.2551.26%-0.5850.55%-0.4516.36%-0.46-12.68%-0.8-37.86%-3.35-50.63%-1.19-152.78%-0.91-66.67%-0.55-208.45%-0.71
Diluted earnings per share 32.84%-2.2551.26%-0.5850.55%-0.4516.36%-0.46-12.68%-0.8-37.86%-3.35-50.63%-1.19-152.78%-0.91-66.67%-0.55-208.45%-0.71
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg